3-53511427-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000350061.11(CACNA1D):​c.483+9707G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.801 in 152,114 control chromosomes in the GnomAD database, including 48,906 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.80 ( 48906 hom., cov: 31)

Consequence

CACNA1D
ENST00000350061.11 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0160

Publications

4 publications found
Variant links:
Genes affected
CACNA1D (HGNC:1391): (calcium voltage-gated channel subunit alpha1 D) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, namely alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1D subunit. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CACNA1D Gene-Disease associations (from GenCC):
  • aldosterone-producing adenoma with seizures and neurological abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • sinoatrial node dysfunction and deafness
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.832 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000350061.11. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
NM_000720.4
MANE Plus Clinical
c.483+9707G>C
intron
N/ANP_000711.1
CACNA1D
NM_001128840.3
MANE Select
c.483+9707G>C
intron
N/ANP_001122312.1
CACNA1D
NM_001128839.3
c.483+9707G>C
intron
N/ANP_001122311.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
ENST00000288139.11
TSL:1 MANE Plus Clinical
c.483+9707G>C
intron
N/AENSP00000288139.3
CACNA1D
ENST00000350061.11
TSL:1 MANE Select
c.483+9707G>C
intron
N/AENSP00000288133.5
CACNA1D
ENST00000481478.2
TSL:1
c.483+9707G>C
intron
N/AENSP00000418014.2

Frequencies

GnomAD3 genomes
AF:
0.801
AC:
121717
AN:
151996
Hom.:
48859
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.820
Gnomad AMI
AF:
0.658
Gnomad AMR
AF:
0.817
Gnomad ASJ
AF:
0.843
Gnomad EAS
AF:
0.853
Gnomad SAS
AF:
0.830
Gnomad FIN
AF:
0.830
Gnomad MID
AF:
0.775
Gnomad NFE
AF:
0.775
Gnomad OTH
AF:
0.788
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.801
AC:
121817
AN:
152114
Hom.:
48906
Cov.:
31
AF XY:
0.805
AC XY:
59847
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.820
AC:
34016
AN:
41498
American (AMR)
AF:
0.818
AC:
12490
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.843
AC:
2928
AN:
3472
East Asian (EAS)
AF:
0.853
AC:
4405
AN:
5166
South Asian (SAS)
AF:
0.830
AC:
3999
AN:
4820
European-Finnish (FIN)
AF:
0.830
AC:
8785
AN:
10578
Middle Eastern (MID)
AF:
0.789
AC:
232
AN:
294
European-Non Finnish (NFE)
AF:
0.775
AC:
52711
AN:
67994
Other (OTH)
AF:
0.783
AC:
1652
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1232
2465
3697
4930
6162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.741
Hom.:
2522
Bravo
AF:
0.803

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.9
DANN
Benign
0.36
PhyloP100
0.016
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs312486; hg19: chr3-53545454; API